Surrey researchers Sign in
SUNITINIB TREATMENT OF RENAL ADJUVANT CANCER (S-TRAC): A RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF SUNITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RENAL CELL CARCINOMA (RCC)
Conference presentation   Peer reviewed

SUNITINIB TREATMENT OF RENAL ADJUVANT CANCER (S-TRAC): A RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF SUNITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RENAL CELL CARCINOMA (RCC)

A Ravaud, RJ Motzer, H Pandha, M Staehler, DJ George, A Pantuck, A Patel, P Gerletti, L Chen and J Patard
ANNALS OF ONCOLOGY, Vol.23, pp.292-293
37th Congress of the European-Society-for-Medical-Oncology (ESMO) (Vienna, AUSTRIA, 28/09/2012 - 02/10/2012)
01/09/2012

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309409001370&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

29 Record Views

Details

Usage Policy